Putnam Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$7.63M Buy
318,097
+160,777
+102% +$3.5M 0.01% 373
2023
Q3
$3.44M Buy
157,320
+13,128
+9% +$275K 0.01% 538
2023
Q2
$2.76M Sell
144,192
-27,481
-16% -$530K ﹤0.01% 675
2023
Q1
$3.33M Sell
171,673
-22,029
-11% -$384K 0.01% 563
2022
Q4
$3.11M Sell
193,702
-2,314
-1% -$37.7K 0.01% 641
2022
Q3
$3.07M Buy
196,016
+7,956
+4% +$154K 0.01% 616
2022
Q2
$3.92M Buy
188,060
+5,086
+3% +$105K 0.01% 509
2022
Q1
$4.15M Buy
+182,974
New +$3.57M 0.01% 597
2017
Q2
Sell
-68,273
Closed -$1.48M 1167
2017
Q1
$1.48M Sell
68,273
-8,709
-11% -$177K ﹤0.01% 919
2016
Q4
$1.15M Sell
76,982
-438
-0.6% -$6.32K ﹤0.01% 976
2016
Q3
$990K Buy
+77,420
New +$837K ﹤0.01% 1024

Other funds holding EXEL

Putnam Investments's EXEL Position: Q4 2023 in Review

Putnam Investments increased its Exelixis (EXEL) stake by 102% in Q4 2023, buying an estimated $3.5M and bringing the position to 318,097 shares worth $7.63M. The position accounts for 0.01% of the portfolio, ranked #373.

Putnam Investments first reported a position in EXEL in Q3 2016 and has held it in 11 quarters since. 425 funds tracked by Wall St. Rank hold EXEL as of Q4 2023.

  • Putnam Investments held 318,097 shares of Exelixis worth $7.63M as of Q4 2023.
  • Putnam Investments bought 160,777 Exelixis shares in Q4 2023, an estimated $3.5M.
  • Exelixis made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #373 holding.
  • Putnam Investments first reported a position in Exelixis in Q3 2016 and has held it in 11 quarters since.
  • 425 funds tracked by Wall St. Rank held Exelixis as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.